Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
自适应 RSK-EphA2-GPRC5A 信号开关引发卵巢癌化疗耐药性
期刊:EMBO Molecular Medicine
影响因子:9
doi:10.15252/emmm.201911177
Lidia Moyano-Galceran, Elina A Pietilä #, S Pauliina Turunen #, Sara Corvigno, Elisabet Hjerpe, Daria Bulanova, Ulrika Joneborg, Twana Alkasalias, Yuichiro Miki, Masakazu Yashiro, Anastasiya Chernenko, Joonas Jukonen, Madhurendra Singh, Hanna Dahlstrand, Joseph W Carlson, Kaisa Lehti
